Blumenol C glucoside



Compound IDCDAMM02631
Common nameBlumenol C glucoside
IUPAC name3,5,5-trimethyl-4-[3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybutyl]cyclohex-2-en-1-one
Molecular formulaC19H32O7

Experimental data

Retention time5.42
Adduct[M+H]+
Actual mz373.227
Theoretical mz373.222
Error12.93
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score5.7817

Identifiers and class information

Inchi keyNYLNHNDMNOPWAZ-UHFFFAOYNA-N
SmilesO=C1C=C(C)C(CCC(OC2OC(CO)C(O)C(O)C2O)C)C(C)(C)C1
SuperclassLipids and lipid-like molecules
ClassFatty Acyls

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)10
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)372.458
Computed dipole moment(dipole)4.305
Total solvent accessible surface area (SASA)618.025
Hydrophobic component of SASA (FOSA)398.86
Hydrophilic component of SASA (FISA)202.504
Pie component of the SASA (PISA)16.661
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1174.51
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)12.2
Free energy of solvation of dipole (dip^2/V)0.0157773
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0394806
Globularity descriptor (glob)0.871091
Predicted polarizability in cubic angstroms (QPpolrz)34.588
Predicted hexadecane/gas partition coefficient (QPlogPC16)11.628
Predicted octanol/gas partition coefficient (QPlogPoct)23.879
Predicted water/gas partition coefficient (QPlogPw)18.367
Predicted octanol/water partition coefficient (QPlogPo/w)0.186
Predicted aqueous solubility (QPlogS)-2.253
Conformation-independent predicted aqueous solubility (CIQPlogS)-2.308
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-3.697
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)119.002
Predicted brain/blood partition coefficient (QPlogBB)-1.818
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)49.56
Predicted skin permeability, log Kp (QPlogKp)-4.233
PM3 calculated ionization potential (IP(ev))10.166
PM3 calculated electron affinity (EA(eV))0.25
Number of likely metabolic reactions (#metab)7
Prediction of binding to human serum albumin (QPlogKhsa)-0.687
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)65.183
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)128.136
Number of nitrogen and oxygen atoms (#NandO)7
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P16109SELPP-selectinT10965SEA
P60568IL2Interleukin-2T61698SEA
P17931LGALS3Galectin-3T72038SEA
P14679TYRTyrosinaseT97035SEA
P06865HEXABeta-hexosaminidase subunit alphaT63196SEA
P07686HEXBBeta-N-acetyl-D-hexosaminidase-A/BT63197SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
P30837ALDH1B1Acetaldehyde dehydrogenaseT99641SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T10965DI0088Circulatory system disease[ICD-11: BE2Z]P16109SELP
T10965DI0381Sickle-cell disorder[ICD-11: 3A51]P16109SELP
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T72038DI0190Hypertension[ICD-11: BA00-BA04]P17931LGALS3
T72038DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]P17931LGALS3
T72038DI0252Melanoma[ICD-11: 2C30]P17931LGALS3
T72038DI0302Non-alcoholic fatty liver disease[ICD-11: DB92]P17931LGALS3
T72038DI0351Psoriasis[ICD-11: EA90]P17931LGALS3
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR
T63196DI0242Lysosomal disease[ICD-11: 5C56]P06865HEXA
T63197DI0242Lysosomal disease[ICD-11: 5C56]P07686HEXB
T99641DI0396Substance abuse[ICD-11: 6C40]P30837ALDH1B1

Copyright © 2025